NCT01101334 - Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Advanced Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG

CS-7017

CS-7017, Two 0.25mg Tablets administered twice daily

DRUG

erlotinib

Erlotinib; One 150mg tablet administered once daily

Trial Locations (17)

44718

Gabrail Cancer Center, Canton

80204

DHHA, Denver

98201

Providence Regional Medical Center Everett, Everett

380009

Vedanta Institute of Medical Sciences, Ahmedabad

400012

Tata Memorial Hospital, Mumbai

431001

Kodlikeri Memorial Hospital, Aurangabad

530002

King George Hospital, Visakhapatnam

625107

Meenakshi Mission Hospital, Madurai

D-82131

Zentrum fur Pneumologie und Thoraxchirurgie, Gauting

411 013

Noble Hospital, Pune

600 035

Apollo Speciality Hospital, Chennai

700 054

Orchid Nursing Home, Kolkata

442-723

St. Vincent's Hospital, Gyeonggi-do

519-763

Hwasun Hospital, Jeonnam

120-752

Severance Hospital, Seoul

135-710

Samsung Medical Center, Seoul

138-736

Asan Medical Center, Seoul